Walgreen to pay more than $2.85 million to settle US overbilling charges
The settlement partially resolves claims against the Walgreens Boots Alliance unit brought under the federal, Georgia and Massachusetts False Claims Act. Walgreen pharmacies were accused of having from 2008 to 2023 submitted elevated "usual and customary" prices for some generic medications to the MassHealth and Georgia Medicaid programs, causing those programs to pay more for the medications than they should have.